HS
OFIX icon

HighVista Strategies’s Orthofix Medical OFIX Stock Holding History

HighVista Strategies’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-85,049
Closed -$1.29M – 172
2025
Q4 		$1.29M Sell
85,049
-8,151
-9% -$124K 0.33% 82
2025
Q3 		$1.36M Sell
93,200
-13,300
-12% -$175K 0.33% 95
2025
Q2 		$1.19M Buy
106,500
+13,600
+15% +$169K 0.44% 96
2025
Q1 		$1.52M Buy
92,900
+18,900
+26% +$332K 0.58% 68
2024
Q4 		$1.29M Sell
74,000
-34,100
-32% -$593K 0.48% 92
2024
Q3 		$1.69M Buy
+108,100
New +$1.73M 0.58% 68
2024
Q2 		– Sell
-167,900
Closed -$2.44M – 151
2024
Q1 		$2.44M Buy
+167,900
New +$2.32M 0.87% 36

Other funds holding OFIX

ECM
Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HighVista Strategies's OFIX Position: Q1 2026 in Review

HighVista Strategies sold out of Orthofix Medical (OFIX) in Q1 2026, closing a stake of 85,049 shares — an estimated $1.29M sold.

HighVista Strategies first reported a position in OFIX in Q1 2024 and held it in 7 quarters. The position peaked at $2.44M in Q1 2024. 147 funds tracked by Wall St. Rank hold OFIX as of Q1 2026.

  • HighVista Strategies reported no remaining Orthofix Medical position as of Q1 2026 after selling out during the quarter.
  • HighVista Strategies sold 85,049 Orthofix Medical shares in Q1 2026, an estimated $1.29M.
  • HighVista Strategies first reported a position in Orthofix Medical in Q1 2024 and held it in 7 quarters.
  • HighVista Strategies's Orthofix Medical position peaked at $2.44M in Q1 2024.
  • 147 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2026.

Based on HighVista Strategies's 13F filing for Q1 2026, filed 15 May 2026.